Fundraising Fox

Alkermes

NASDAQ: ALKS

Founded 1987 · 2,446 employees on LinkedIn · 2 known investors

Alkermes develops pharmaceutical medicines for psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders. The company leverages neuroscience expertise to create treatments for patients with complex conditions that are traditionally underserved.

BiotechHealthtechMedical Devices

Investors · 2

Cardinal PartnersPrincetonvia John Clarke · led
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M

Competitors · 1

by search overlap
Medscape131 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.

Companies competing with Alkermes for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Alkermes to Report Second Quarter Financial Results on July 28, 2026 - BioSpacebiospace.com · Jul 2026TD Cowen raises Alkermes stock price target to $57 on drug data By Investing.comin.investing.com · Jul 2026Is Alkermes (ALKS) Fully Priced As Russell 2000 Index Inclusion Draws Fresh Attention? - Simply Wall St Newssimplywall.st · Jul 2026Mizuho raises Alkermes stock price target to $65 on narcolepsy drug potential By Investing.cominvesting.com · Jul 2026BofA downgrades Alkermes stock rating on valuation concerns By Investing.cominvesting.com · Jun 2026Alkermes (ALKS) Advances Alixorexton As Valuation Debate Follows Phase 2 Narcolepsy Data - Simply Wall St Newssimplywall.st · Jun 2026

Frequently asked questions

What does Alkermes do?
Alkermes develops pharmaceutical medicines for psychiatric and neurological disorders, including addiction, serious mental illness, and sleep disorders. The company leverages neuroscience expertise to create treatments for patients with complex conditions that are traditionally underserved.
Who are Alkermes's investors?
Alkermes's investors include Cardinal Partners, Hatteras Venture Partners.